267 related articles for article (PubMed ID: 29888876)
1. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
2. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
3. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
4. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
5. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
[TBL] [Abstract][Full Text] [Related]
6. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Naitoh A; Aoyagi Y; Asakura H
J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
[TBL] [Abstract][Full Text] [Related]
7. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
[TBL] [Abstract][Full Text] [Related]
8. Absolute Quantification of
Kim KH; Lee SY; Kim DG; Lee SY; Kim JY; Yoo JS
Anal Chem; 2020 Sep; 92(18):12588-12595. PubMed ID: 32786443
[TBL] [Abstract][Full Text] [Related]
9. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
[TBL] [Abstract][Full Text] [Related]
10. Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.
Wu M; Liu Z; Zhang A; Li N
Int J Biol Markers; 2019 Mar; 34(1):20-26. PubMed ID: 30854929
[TBL] [Abstract][Full Text] [Related]
11. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
14. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
[TBL] [Abstract][Full Text] [Related]
15. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
[TBL] [Abstract][Full Text] [Related]
16. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
[TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
19. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
[TBL] [Abstract][Full Text] [Related]
20. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
